Insulin efsitora alfa

Onswik

3,000UNITS/3ML InjectionUnited StatesMarketedAuthorised 23 Sept 2026

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Onswik 1000 Unidades/ML Solucion Inyectable en Pluma PrecargadaSpain · 1000 U/ml · solución inyectable · Eli Lilly Nederland B.V.Same brand
Onswik 500 Unidades/ML Solucion Inyectable en Pluma PrecargadaSpain · 500 U/ml · solución inyectable · Eli Lilly Nederland B.V.Same brand
OnswikCroatiaSame brand
Onswik 1.000 eenheden/ml oplossing voor injectie in voorgevulde penNetherlands · Oplossing voor injectie · Eli Lilly Nederland B.V.Same brand
Onswik 500 eenheden/ml oplossing voor injectie in voorgevulde penNetherlands · Oplossing voor injectie · Eli Lilly Nederland B.V.Same brand

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Insulin efsitora alfa

Onswik

3,000UNITS/3ML InjectionUnited StatesMarketedAuthorised 23 Sept 2026

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Register entryFDA

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

U.S. Food and Drug Administration

FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.

Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions · Added 11 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Insulin efsitora alfa
Strength: 3,000UNITS/3ML
Dosage form: Injection
Route: Subcutaneous
Register: United States (FDA)
Status: Marketed
Status in the register: Licensed / Rx
Authorised: 23 Sept 2026
Registration: BLA 761408
Marketing authorisation holder: Eli Lilly and Company
Procedure: 351(a)
Supply: Rx